Advertisement
U.S. markets closed

VKTX Nov 2024 85.000 call

OPR - OPR Delayed Price. Currency in USD
0.10000.0000 (0.00%)
As of 03:23PM EST. Market open.
Full screen
Previous Close0.1000
Open0.0500
Bid0.0000
Ask0.2500
Strike85.00
Expire Date2024-11-22
Day's Range0.0500 - 0.1000
Contract RangeN/A
Volume19
Open Interest68
  • Motley Fool

    3 Monster Stocks in the Making

    Here's why they think biotech stocks CRISPR Therapeutics (NASDAQ: CRSP), Summit Therapeutics (NASDAQ: SMMT), and Viking Therapeutics (NASDAQ: VKTX) could become much larger. David Jagielski (CRISPR Therapeutics): If you're looking for stocks with mammoth upside, you might be tempted to look for risky stocks that don't have any approved drugs or treatments yet. In December 2023, regulators approved Casgevy, which is a gene-editing therapy the company has been developing with Vertex Pharmaceuticals.

  • Investor's Business Daily

    RFK Jr. Spooks Weight-Loss Stocks. Should Eli Lilly, Novo Nordisk Be Worried?

    Robert F. Kennedy Jr.'s potential appointment to HHS has spooked Eli Lilly stock and stocks tied to popular weight-loss drugs.